7.86
price down icon1.13%   -0.09
pre-market  시장 영업 전:  7.66   -0.20   -2.54%
loading
전일 마감가:
$7.95
열려 있는:
$7.96
하루 거래량:
1.31M
Relative Volume:
0.76
시가총액:
$483.24M
수익:
$91.06M
순이익/손실:
$-503.14M
주가수익비율:
-0.9368
EPS:
-8.39
순현금흐름:
$-424.74M
1주 성능:
-7.85%
1개월 성능:
+7.67%
6개월 성능:
+12.93%
1년 성능:
-56.09%
1일 변동 폭
Value
$7.72
$7.96
1주일 범위
Value
$7.72
$8.81
52주 변동 폭
Value
$4.62
$17.79

Sage Therapeutics Inc Stock (SAGE) Company Profile

Name
명칭
Sage Therapeutics Inc
Name
전화
617-299-8380
Name
주소
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Name
직원
487
Name
트위터
@SageBiotech
Name
다음 수익 날짜
2025-02-11
Name
최신 SEC 제출 서류
Name
SAGE's Discussions on Twitter

SAGE을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
SAGE
Sage Therapeutics Inc
7.86 483.24M 91.06M -503.14M -424.74M -8.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.74 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
617.00 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
567.09 34.59B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
255.76 33.10B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
271.04 29.15B 3.81B -644.79M -669.77M -6.24

Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-11 재개 BofA Securities Underperform
2024-11-21 업그레이드 RBC Capital Mkts Underperform → Sector Perform
2024-10-10 재개 Raymond James Mkt Perform
2024-10-04 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2024-07-30 다운그레이드 TD Cowen Buy → Hold
2024-07-25 다운그레이드 JP Morgan Overweight → Neutral
2024-05-29 개시 Citigroup Sell
2024-05-29 개시 Robert W. Baird Neutral
2024-04-17 다운그레이드 BofA Securities Neutral → Underperform
2023-12-12 개시 Deutsche Bank Hold
2023-08-08 다운그레이드 Canaccord Genuity Buy → Hold
2023-08-08 다운그레이드 Goldman Buy → Neutral
2023-08-08 다운그레이드 Needham Buy → Hold
2023-08-07 다운그레이드 BofA Securities Buy → Neutral
2023-08-07 다운그레이드 Oppenheimer Outperform → Perform
2023-08-07 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2023-08-07 다운그레이드 Stifel Buy → Hold
2023-08-07 다운그레이드 Wedbush Outperform → Neutral
2023-07-27 개시 Scotiabank Sector Outperform
2023-03-13 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2023-01-03 다운그레이드 Guggenheim Buy → Neutral
2022-11-01 개시 Loop Capital Hold
2022-03-31 개시 Berenberg Hold
2021-11-02 업그레이드 Guggenheim Neutral → Buy
2021-10-19 재개 Morgan Stanley Equal-Weight
2021-10-07 다운그레이드 Jefferies Buy → Hold
2021-09-23 개시 Needham Buy
2021-06-16 다운그레이드 Citigroup Buy → Neutral
2021-04-07 개시 Piper Sandler Overweight
2021-02-26 다운그레이드 Mizuho Buy → Neutral
2021-02-25 재확인 H.C. Wainwright Neutral
2021-02-02 재개 Raymond James Mkt Perform
2021-01-22 다운그레이드 BMO Capital Markets Outperform → Market Perform
2021-01-04 업그레이드 Guggenheim Neutral → Buy
2021-01-04 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2020-12-04 업그레이드 Mizuho Neutral → Buy
2020-12-01 다운그레이드 Raymond James Outperform → Mkt Perform
2020-11-16 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-11-06 재확인 H.C. Wainwright Neutral
2020-09-11 업그레이드 Wedbush Neutral → Outperform
2020-08-10 업그레이드 Raymond James Mkt Perform → Outperform
2020-05-08 다운그레이드 Wedbush Outperform → Neutral
2020-04-08 다운그레이드 Guggenheim Buy → Neutral
2020-03-18 업그레이드 RBC Capital Mkts Sector Perform → Outperform
2020-03-06 개시 Citigroup Buy
2020-02-28 재확인 H.C. Wainwright Neutral
2020-02-06 개시 Mizuho Neutral
2019-12-06 재확인 RBC Capital Mkts Outperform
2019-12-05 재확인 Guggenheim Buy
2019-12-05 다운그레이드 SunTrust Buy → Hold
2019-10-30 개시 H.C. Wainwright Neutral
2019-05-23 개시 Wedbush Outperform
2019-04-25 개시 Jefferies Buy
2018-12-14 개시 Wolfe Research Outperform
2018-10-11 개시 Oppenheimer Outperform
모두보기

Sage Therapeutics Inc 주식(SAGE)의 최신 뉴스

pulisher
Apr 01, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Shareholders to Inquire about Securities Investigation - markets.businessinsider.com

Apr 01, 2025
pulisher
Mar 30, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Connect - markets.businessinsider.com

Mar 30, 2025
pulisher
Mar 29, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World

Mar 29, 2025
pulisher
Mar 28, 2025

SAGE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc.SAGE - The Malaysian Reserve

Mar 28, 2025
pulisher
Mar 28, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Rating of “Hold” by Analysts - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - Markets Insider

Mar 27, 2025
pulisher
Mar 27, 2025

Sage Therapeutics ($SAGE) Failed Drug Launch and Misleading FDA Guidance Case - TradingView

Mar 27, 2025
pulisher
Mar 27, 2025

Status Epilepticus Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Marinus Pharma, Pfizer, UCB Biopharma SRL, Sage Therapeutics, Shire - The Globe and Mail

Mar 27, 2025
pulisher
Mar 27, 2025

How To Trade (SAGE) - Stock Traders Daily

Mar 27, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Has $931,000 Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Mar 26, 2025
pulisher
Mar 25, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation - Markets Insider

Mar 25, 2025
pulisher
Mar 22, 2025

Amundi Invests $166,000 in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Mar 22, 2025
pulisher
Mar 19, 2025

Investors who hold shares of Sage Therapeutics, Inc. (NASDAQ: - openPR.com

Mar 19, 2025
pulisher
Mar 18, 2025

US Bancorp DE Acquires 2,268 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Notice to Long-Term Shareholders of Fluence Energy, Inc. - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc.SAGE - Business Wire

Mar 17, 2025
pulisher
Mar 16, 2025

Sage moved to Underperform at BofA; says Biogen’s buyout impact has passed - MSN

Mar 16, 2025
pulisher
Mar 15, 2025

Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on You - The Globe and Mail

Mar 15, 2025
pulisher
Mar 14, 2025

Notice to Long-Term Shareholders of Mercury Systems, Inc. - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims - Morningstar

Mar 14, 2025
pulisher
Mar 14, 2025

Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.

Mar 14, 2025
pulisher
Mar 13, 2025

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Be - TradingView

Mar 13, 2025
pulisher
Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Mar 13, 2025
pulisher
Mar 13, 2025

Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

Long-Term Shareholder Notice: Driven Brands Holdings, Inc. - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Sage Therapeutics (NASDAQ:SAGE) Now Covered by Analysts at Bank of America - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

Sage Therapeutics stock rated Underperform at BofA (SAGE) - Seeking Alpha

Mar 11, 2025
pulisher
Mar 11, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation - Markets Insider

Mar 11, 2025
pulisher
Mar 10, 2025

Sage Therapeutics resumed with an Underperform at BofA - TipRanks

Mar 10, 2025
pulisher
Mar 10, 2025

Attention Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire

Mar 10, 2025
pulisher
Mar 09, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Reach Out - Markets Insider

Mar 09, 2025
pulisher
Mar 07, 2025

SAGE Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld Online

Mar 07, 2025
pulisher
Mar 06, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - Markets Insider

Mar 06, 2025
pulisher
Mar 05, 2025

Sage’s medical chief is latest leader to leave biotech - The Business Journals

Mar 05, 2025
pulisher
Mar 05, 2025

Sage Therapeutics CMO to leave for new opportunity By Investing.com - Investing.com Canada

Mar 05, 2025
pulisher
Mar 04, 2025

Sage Therapeutics Announces R&D Leadership Transition - citybiz

Mar 04, 2025
pulisher
Mar 04, 2025

Sage Therapeutics announces CMO resignation By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

Sage Therapeutics announces CMO resignation - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

SAGE Therapeutics Announces CMO Resignation and Interim Appointment - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

SAGE Therapeutics Announces Research And Development Leadership Transition -March 04, 2025 at 04:49 pm EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

Sage Therapeutics CMO to leave for new opportunity - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

SAGE Therapeutics (SAGE) Announces R&D Leadership Transition - StreetInsider.com

Mar 04, 2025
pulisher
Mar 04, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Markets Insider

Mar 04, 2025
pulisher
Mar 04, 2025

Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAGE - accessnewswire.com

Mar 04, 2025
pulisher
Mar 03, 2025

Levi & Korsinsky Reminds Sage Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 03, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Recommendation of “Hold” from Analysts - Defense World

Mar 03, 2025
pulisher
Mar 01, 2025

Sage Therapeutics, Inc. (SAGE): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey

Mar 01, 2025

Sage Therapeutics Inc (SAGE) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
자본화:     |  볼륨(24시간):